EPAC inhibitor. Inhibits EPAC-mediated insulin releases from pancreatic β
cells. Selective for EPAC over PKA. Decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells in vitro
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion.
Almahariq et al.
The citations listed below are publications that use Tocris products. Selected citations for ESI 09 include:
Showing Results 1 - 1 of 1